Anna Muzalyova
Overview
Explore the profile of Anna Muzalyova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manz R, Backer J, Cramer S, Meyer P, Muller D, Muzalyova A, et al.
J Pathol Clin Res
. 2025 Mar;
11(2):e70023.
PMID: 40079401
This work aimed to evaluate both the usefulness and user acceptance of five gradient-based explainable artificial intelligence (XAI) methods in the use case of a prostate carcinoma clinical decision support...
2.
Scheppach M, Mendel R, Muzalyova A, Rauber D, Probst A, Nagl S, et al.
Endoscopy
. 2025 Feb;
PMID: 39909396
Background And Study Aims: While artificial intelligence (AI) shows high potential in decision support for diagnostic gastrointestinal endoscopy, its role in therapeutic endoscopy remains unclear. Third space endoscopic procedures pose...
3.
Ayoub M, Muzalyova A, Ebigbo A, Nagl S, Rommele C, Classen J, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768635
: Inflammatory bowel disease (IBD) frequently manifests at a young age, during the peak fertility years. Understanding the risks of negative pregnancy outcomes associated with IBD is crucial for effective...
4.
Classen J, Muzalyova A, Rommele C, Nagl S, Ebigbo A, Schnoy E
Dig Dis
. 2024 Dec;
43(1):19-27.
PMID: 39616993
Introduction: Patients with inflammatory bowel disease (IBD) receiving immunosuppressive therapy might have an increased risk of developing a severe course of SARS-CoV-2 infection. The aim of this study was to...
5.
Wanzl J, Hofer S, Schwamberger T, Tadic V, Muzalyova A, Hainsch-Muller I, et al.
Endosc Int Open
. 2024 Nov;
12(11):E1411-E1416.
PMID: 39610950
Bowel obstruction is a common complication in advanced cancer patients. Patients are restricted in quality of life (QOL) due to nausea, vomiting, or abdominal pain. Prospective data on the feasibility...
6.
Riedl K, Probst A, Ebigbo A, Steinbruck I, Allgaier H, Albers D, et al.
J Clin Med
. 2024 Sep;
13(18).
PMID: 39337025
Endoscopic submucosal dissection (ESD) has become a standard treatment for early gastric cancer (EGC), often fulfilling guideline criteria (GC) or expanded criteria (EC). When lesions exceed the EC, surgical resection...
7.
Scheppach M, Nagl S, Muzalyova A, Classen J, Messmann H, Ebigbo A
Gastrointest Endosc
. 2024 Aug;
101(1):207-212.
PMID: 39117238
Background And Aims: Endoscopic hand suturing (EHS) is a new technique for the closure of mucosal defects in the GI tract. Although this method was tested for wound closure after...
8.
Grunherz V, Ebigbo A, Elia M, Brunner A, Krafft T, Poller L, et al.
BMJ Open Gastroenterol
. 2024 Jun;
11(1).
PMID: 38844375
Background And Aims: Peroral endoscopic myotomy (POEM) is a standard treatment option for achalasia patients. Treatment response varies due to factors such as achalasia type, degree of dilatation, pressure and...
9.
Meinikheim M, Mendel R, Palm C, Probst A, Muzalyova A, Scheppach M, et al.
Endoscopy
. 2024 Mar;
56(9):641-649.
PMID: 38547927
Background: This study evaluated the effect of an artificial intelligence (AI)-based clinical decision support system on the performance and diagnostic confidence of endoscopists in their assessment of Barrett's esophagus (BE)....
10.
Probst A, Kappler F, Ebigbo A, Albers D, Faiss S, Steinbruck I, et al.
Gastrointest Endosc
. 2024 Mar;
100(4):626-636.
PMID: 38479623
Background And Aims: Endoscopic resection is accepted as standard treatment for intramucosal esophageal adenocarcinoma (EAC) that is well or moderately differentiated. Poor differentiation (PD) is judged as a risk factor...